DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, et al
Round up to leave a margin for priming losses and dropped syringes
Over the course of 40 weeks, TZP exhibited a remarkable average increase of 97-120% in HOMA2-B, calculated with C-peptide, compared to 84% with SEMA
00:07:00 Vickie Danaher But injectable tirzepatide or Zepbound achieves more, about 41 pounds more weight loss than placebo over a year in patients without diabetes
However, severe or unusual headaches, especially when accompanied by other concerning symptoms, should prompt immediate medical attention
ZP CON CBS 08NOV2023 Zepbound and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates